Andy Roddick defends Serena Williams' GLP-1 weight loss amid comeback talk

Former tennis star Andy Roddick has voiced support for Serena Williams' use of GLP-1 medication in her weight-loss efforts, suggesting it could aid a potential return to the court. Williams has shared how the treatment improved her health, while speculation grows following her inclusion in the anti-doping pool and practice sessions with younger players. Roddick emphasized the benefits for injury prevention during training.

In a recent episode of the Served podcast, Andy Roddick addressed criticism of Serena Williams' use of GLP-1 medication for weight loss. He stated that if he were attempting a comeback, he would prioritize rapid weight reduction to facilitate safer training. "I can tell you something that I think I know for a fact, right? I’m not Serena. I can’t play anymore. I stink. And if I decided that I wanted to come back, guess what I would be doing immediately? Immediately, I’d be dropping 20 pounds as fast as I can," Roddick said.

Roddick argued that starting lighter reduces injury risks during preparation, which is a major hurdle for returning athletes. "I would be taking those drugs because you know what becomes easier when you are 20 pounds lighter? Actually, getting back to the training that you need without getting injured to get back on tour," he explained. He added, "What it does is shortens the timeline for training and mitigates a lot of the risk in because the thing with getting back is like you get injured training, injured training, injured training, you can’t get back. Right."

Williams first discussed her use of the medication in an August 2025 interview with People Magazine and reinforced it in a Super Bowl XL advertisement in 2026. In a January 2026 interview with Today.com, she highlighted health improvements: "My blood sugar is better. I was able to lower my cholesterol by 30%. Some of these numbers [previous high cholesterol levels] are from when I was literally winning Grand Slams. It wasn’t, like, just playing tennis. I was dominating. I was at risk for heart disease, and I didn’t even know. … That’s scary."

Comeback rumors intensified after Williams' name appeared in the tennis anti-doping testing pool, a step often required for returning players. On the Today show in January 2026, she responded ambiguously: "I’m just having fun and enjoying my life right now," adding, "I don’t know, I’m just going to see what happens."

American player Alycia Parks recently practiced with Williams and commented on her fitness. "I actually practiced with her last Monday. And I messaged her yesterday. She’s definitely a good mentor to me, and she’s helped me a lot, especially in my practices," Parks told Tennis Majors. She added, "She is in great shape. So I think she would kill it on tour."

Support for Williams continues to build in the tennis community as discussions of a potential return, possibly emulating sister Venus, persist.

Artículos relacionados

Realistic illustration contrasting social stigma: neutral for overweight, positive for exercise weight loss, negative for Ozempic users.
Imagen generada por IA

Un estudio revela que las personas que utilizan fármacos similares al Ozempic para perder peso enfrentan un estigma adicional

Reportado por IA Imagen generada por IA Verificado por hechos

Las personas que pierden peso utilizando medicamentos GLP-1, como Ozempic y Wegovy, pueden ser juzgadas con mayor severidad que aquellas que lo logran mediante dieta y ejercicio —e incluso de forma más negativa que quienes no pierden peso en absoluto—, según un nuevo estudio dirigido por la psicóloga de la Universidad Rice, Erin Standen.

Alycia Parks, tras su victoria en primera ronda del Abierto de Miami, aportó sus impresiones sobre el actual estado de forma tenística de Serena Williams en sus sesiones de entrenamiento. La número 105 del mundo describió a Williams como una jugadora en forma y con buenos golpes, aunque sigue sin estar segura de volver a jugar profesionalmente. Parks atribuye a las sesiones la mejora de su propio juego.

Reportado por IA

Teddi Mellencamp, exintegrante de Real Housewives of Beverly Hills, reveló en su podcast que le suplicó a su médico que le recetara medicamentos GLP-1 para perder peso mientras luchaba contra el cáncer. Ella aumentó de peso debido a los esteroides, pero su médico se negó. Bromeando sobre la ironía, ironizó acerca de vivir su mejor vida sin los medicamentos.

La tenista canadiense Bianca Andreescu se ha sincerado sobre el lado oscuro de su victoria en el US Open de 2019, incluyendo el cambio en sus relaciones y la inseguridad personal. En una reciente entrevista en un podcast, la jugadora de 25 años detalló cómo la fama repentina provocó que la gente le pidiera favores y cuestionara sus logros. Actualmente, protagoniza un sólido regreso con un registro de 19-6 esta temporada.

Reportado por IA

Científicos han desarrollado un tratamiento híbrido contra la obesidad que utiliza señales de GLP-1 y GIP para administrar un potenciador metabólico directamente en las células. Las pruebas iniciales en ratones mostraron una mayor pérdida de peso y un mejor control del azúcar en sangre que las terapias estándar. El enfoque tiene como objetivo reducir los efectos secundarios al limitar la acción del fármaco a áreas específicas.

Este sitio web utiliza cookies

Utilizamos cookies para análisis con el fin de mejorar nuestro sitio. Lee nuestra política de privacidad para más información.
Rechazar